MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
MGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MacroGenics (MGNX) Ownership - Who owns MacroGenics?

Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
9704 Medical Center Drive
Phone
+1 301 251-5172
Employees
293
Web
https://www.macrogenics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
248.53M
P/E Ratio
N/A
Total Cash
154.23M
Projected Growth
N/A
Total Debt
36.51M
Revenue
157.08M
Risk (Beta)
0.69
Dividend Yield
N/A
Total Cash/Share
2.43
Total Debt/Equity
N/A
Revenue/Share
2.48 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
MGNX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for MGNX
A.I. Advisor
published General Information

General Information

a company, which engages in the discovery and development of monoclonal antibody-based therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
9704 Medical Center Drive
Phone
+1 301 251-5172
Employees
293
Web
https://www.macrogenics.com